Inventor · disambiguated record
Benny C. Askew, Jr.
Also filed as: ASKEW BENNY · ASKEW BENNY C · ASKEW BENNY C JR · ASKEW JR BENNY C
25 granted patents·16 pending applications·598 citations·filing 1997–2024
96Inventor score
Top patents by PatentIndex Score
41 records- 0197US10759828B2Neuroactive steroids, compositions, and uses thereofSAGE THERAPEUTICS INC·Filed 2018·Granted Sep 1, 2020·15 cites·1 claims
- 0296US6645990B2Thiazolyl urea compounds and methods of usesAMGEN INC·Filed 2002·Granted Nov 11, 2003·172 cites·18 claims
- 0395US7196104B2Thiazolyl urea compounds and methods of usesAMGEN INC·Filed 2003·Granted Mar 27, 2007·120 cites·13 claims
- 0495US6878714B2Substituted alkylamine derivatives and methods of useAMGEN INC·Filed 2002·Granted Apr 12, 2005·85 cites·39 claims
- 0594US12129275B2Neuroactive steroids, compositions, and uses thereofSAGE THERAPEUTICS INC·Filed 2022·Granted Oct 29, 2024·2 cites·18 claims
- 0694US10435431B23,3 disubstituted 19-nor pregnane compounds, compositions, and uses thereofSAGE THERAPEUTICS INC·Filed 2017·Granted Oct 8, 2019·10 cites·1 claims
- 0791US8815872B2Macrocyclics pyrimidines as aurora kinase inhibitorsYU HENRY·Filed 2009·Granted Aug 26, 2014·24 cites·5 claims
- 0891US8076486B2Heteroaryl-substituted arylaminopyridine derivatives as MEK inhibitorsGOUTOPOULOS ANDREAS·Filed 2007·Granted Dec 13, 2011·25 cites·21 claims
- 0991US7102009B2Substituted amine derivatives and methods of useAMGEN INC·Filed 2002·Granted Sep 5, 2006·49 cites·20 claims
- 1089US7531553B2Heterocyclic compounds and methods of useAMGEN INC·Filed 2004·Granted May 12, 2009·44 cites·15 claims
- 1185US7101868B2Substituted arylamine derivatives and methods of useAMGEN INC·Filed 2004·Granted Sep 5, 2006·20 cites·36 claims
- 1285US2025257092A1Neuroactive steroids, compositions, and uses thereofSAGE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1380US7320992B2Substituted 2,3-dihydro-1h-isoindol-1-one derivatives and methods of useAMGEN INC·Filed 2004·Granted Jan 22, 2008·15 cites·38 claims
- 1479US2023287037A13,3 disubstituted 19-nor pregnane compounds, compositions, and uses thereofSAGE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1576US2020223884A13,3 disubstituted 19-nor pregnane compounds, compositions, and uses thereofSAGE THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1675US7414134B2B1 bradykinin receptor antagonistsAMGEN INC·Filed 2005·Granted Aug 19, 2008·2 cites·31 claims
- 1773US8404725B2Phenylamino isonicotinamide compoundsGOUTOPOULOS ANDREAS·Filed 2009·Granted Mar 26, 2013·1 cites·5 claims
- 1872US7772233B2Arylamino N-heteroaryl compounds as MEK inhibitorsMERCK SERONO SA·Filed 2007·Granted Aug 10, 2010·1 cites·13 claims
- 1972US7605120B2Antagonists of the brandykinin B1 receptorAMGEN INC·Filed 2004·Granted Oct 20, 2009·2 cites·11 claims
- 2072US2009048149A1Antagonists of the bradykinin B1 receptorAMGEN INC·Filed 2008·Application pending·0 cites
- 2171US2021040141A13,3 disubstituted 19-nor pregnane compounds, compositions, and uses thereofSAGE THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2270US7662811B21,2,3,4-tetrahydropyrazin-2-yl acetamides and methods of useAMGEN INC·Filed 2005·Granted Feb 16, 2010·1 cites·13 claims
- 2369US2021147470A1Neuroactive steroids, compositions, and uses thereofSAGE THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2467US8802703B2Arylamino N-heteraryl compounds as MEK inhibitorsGOUTOPOULOS ANDREAS·Filed 2010·Granted Aug 12, 2014·1 cites·1 claims
- 2565US8288351B2Antagonists of the bradykinin B1 receptorNG GORDON·Filed 2008·Granted Oct 16, 2012·0 cites·14 claims
- 2665US8278280B2Antagonists of the bradykinin B1 receptorNG GORDON·Filed 2008·Granted Oct 2, 2012·0 cites·14 claims
- 2765US7425631B2Compounds and methods of useAMGEN INC·Filed 2004·Granted Sep 16, 2008·2 cites·6 claims
- 2864US7199244B2Cyclic amine derivatives and methods of useARRAY BIOPHARMA INC·Filed 2004·Granted Apr 3, 2007·2 cites·48 claims
- 2959US2015291654A13,3 disubstituted 19-nor pregnane compounds, compositions, and uses thereofSAGE THERAPEUTICS INC·Filed 2012·Application pending·0 cites
- 3058US2015158903A1Neuroactive steroids, compositions, and uses thereofUPASANI RAVINDRA B·Filed 2012·Application pending·0 cites
- 3157US2009048224A1Compounds and methods of useAMGEN INC·Filed 2008·Application pending·0 cites
- 3257US2005153960A1Substituted arylamine derivatives and methods of useAMGEN INC·Filed 2004·Application pending·0 cites
- 3356US2008249106A1Novel B1 bradykinin receptor antagonistsAMGEN INC·Filed 2008·Application pending·0 cites
- 3454US8889719B2Phenylamino isonicotinamide compoundsGOUTOPOULOS ANDREAS·Filed 2013·Granted Nov 18, 2014·0 cites·14 claims
- 3552US8853391B2Tricyclic azaindolesHUCK BAYARD R·Filed 2009·Granted Oct 7, 2014·0 cites·6 claims
- 3651US5952306AIntegrin receptor antagonistsMERCK & CO INC·Filed 1997·Granted Sep 14, 1999·5 cites·8 claims
- 3751US2003134836A1Substituted arylamine derivatives and methods of useAMGEN INC·Filed 2002·Application pending·0 cites
- 3850US2011282056A1Protein kinase inhibitors and use thereofASKEW BENNY C·Filed 2009·Application pending·0 cites
- 3944US2006199812A1Method of conjugating aminothiol containing molecules to vehiclesAMGEN INC·Filed 2006·Application pending·0 cites
- 4044US2006111347A1Substituted sulfones and methods of useAMGEN INC·Filed 2005·Application pending·0 cites
- 4138US2002173507A1Urea compounds and methods of usesFiled 2001·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →